Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

How immune-based interventions can change HIV therapy

¹Department of Medicine, Centre Hospitalier Universitaire Vadois, Lausanne, Switzerland.

Nature Medicine

|May 1, 1997

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enrichment of CD7<sup>+</sup>CXCR3<sup>+</sup> CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.

The Journal of infection·2022

Same author

Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.

BMC nephrology·2021

Same author

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.

Journal of virology·2021